[1]
Palacek, E.; Scheller, F.; Wang, J. Electrochemistry of Nucleic Acids and Proteins:Towards Electrochemical Sensors for Genomics and Proteomics; Elsevier Science: Amsterdam, 2005.
[2]
Gosser, D.K. Cyclic voltammetry: Simulation and Analysis of Reaction Mechanisms; VCH Publishers: New York, 1994.
[3]
Vire, J.C.; Kauffmann, J-M. Trends in electrochemistry in drug analysis. Curr. Top. Electrochem., 1994, 3, 493-515.
[4]
Brown, E.R.; Large, R.F.; Weissberg, A.; Rossiter, B.W. Physical Methods of Chemistry; Wiley Interscience: New York, 1964.
[5]
Ozkan, S.A. Electroanalytical Methods in Pharmaceutical Analysis and Their Validation , 1st ed.; HNB Pub, Palenville. 2012.
[6]
Zhang, X.; Ju, H.; Wang, J. Electrochemical sensors, biosensors and their biomedical applications; Elsevier: Amsterdam, 2008.
[7]
Brett, C.M.A. Electrochemistry. Principles, Methods and Applications; Oxford University Press: Oxford, 1993.
[8]
Greef, R.; Peat, R.; Peter, L.M.; Pletcher, D. Instrumental Methods in Electrochemistry; Ellis Horwood: Amsterdam, 1990.
[9]
Hart, J.P. Electroanalysis of Biologically Important Compounds; Ellis Horwood: Amsterdam, 1990.
[10]
Harvey, D. Modern Analytical Chemistry, 1st ed; The McGraw-Hill Companies, Inc., 2000.
[11]
Cheraghi, S.; Taher, M.A.; Karimi-Maleh, H. Highly sensitive square wave voltammetric sensor employing CdO/SWCNTs and room temperature ionic liquid for analysis of vanillin and folic acid in food samples. J. Food Compos. Anal., 2017, 62, 254-259.
[12]
Tahernejad-Javazmi, F.; Shabani-Nooshabadi, M.; Karimi-Maleh, H. Analysis of glutathione in the presence of acetaminophen and tyrosine via an amplified electrode with MgO/SWCNTs as a sensor in the hemolyzed erythrocyte. Talanta, 2018, 176, 208-213.
[13]
Alavi-Tabari, S.A.R.; Khalilzadeh, M.A.; Karimi-Maleh, H. Simultaneous determination of doxorubicin and dasatinib as two breast anticancer drugs uses an amplified sensor with ionic liquid and ZnO nanoparticle. J. Electroanal. Chem., 2018, 811, 84-88.
[14]
Karimi-Maleh, H.; Bananezhad, A.; Ganjali, M.R.; Norouzi, P.; Sadrnia, A. Surface amplification of pencil graphite electrode with polypyrrole and reduced graphene oxide for fabrication of a guanine/adenine DNA based electrochemical biosensors for determination of didanosine anticancer drug. Appl. Surf. Sci., 2018, 441, 55-60.
[15]
Tseng, C-C.; Wolfe, M.M. Nonsteroidal anti-inflammatory drugs. Med. Clin. North Am., 2000, 84(5), 1329-1344.
[16]
Murray, M.D.; Brater, D.C. Nonsteroidal anti-inflammatory drugs. Clin. Geriatr. Med., 1990, 6(2), 365-397.
[17]
Dugowson, C.E.; Gnanashanmugam, P. Nonsteroidal anti-inflammatory drugs. Phys. Med. Rehabil. Clin. N. Am., 2006, 17(2), 347-354.
[18]
Girgis, L.; Brooks, P. Nonsteroidal anti-inflammatory drugs. Drugs Aging, 1994, 4(2), 101-112.
[19]
Mills, J.A. Nonsteroidal anti-inflammatory drugs. N. Engl. J. Med., 1974, 290(14), 781-784.
[20]
Carson, J.L.; Strom, B.L.; Morse, M.L.; West, S.L.; Soper, K.A.; Stolley, P.D.; Jones, J.K. The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch. Intern. Med., 1987, 147(6), 1054.
[21]
Gabriel, S.E.; Jaakkimainen, L.; Bombardier, C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. Ann. Intern. Med., 1991, 115(10), 787.
[22]
Vane, J.; Botting, R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J., 1987, 1(2), 89-96.
[23]
Goodwin, J.S.; Regan, M. Cognitive dysfunction associated with naproxen and ibuprofen in the elderly. Arthritis Rheum., 1982, 25(8), 1013-1015.
[24]
Netter, P.; Lapicque, F.; Bannwarth, B.; Tamisier, J.N.; Thomas, P.; Royer, R.J. Diffusion of intramuscular ketoprofen into the cerebrospinal fluid. Eur. J. Clin. Pharmacol., 1985, 29(3), 319-321.
[25]
Starek, M. Review of the applications of different analytical techniques for coxibs research. Talanta, 2011, 85(1), 8-27.
[26]
Peesa, J.P.; Yalavarthi, P.R.; Rasheed, A.; Mandava, V.B.R. A perspective review on role of novel NSAID prodrugs in the management of acute inflammation. J. Acute Dis., 2016, 5(5), 364-381.
[27]
Ardoin, S.P.; Sundy, J.S. Update on nonsteriodal anti-inflammatory drugs. Curr. Opin. Intern. Med, 2006, 5(4), 372-377.
[28]
VANE J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat. New Biol., 1971, 231(25), 232-235.
[29]
Kato, M.; Nishida, S.; Kitasato, H.; Sakata, N.; Kawai, S. Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of Non-Steroidal anti-inflammatory drugs: investigation using human peripheral monocytes. J. Pharm. Pharmacol., 2001, 53(12), 1679-1685.
[30]
Cryer, B.; Feldman, M. Cyclooxygenase-1 and Cyclooxygenase-2 Selectivity of widely used nonsteroidal anti-inflammatory drugs. Am. J. Med., 1998, 104(5), 413-421.
[31]
Nageswara Rao, R.; Meena, S.; Raghuram Rao, A. An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matrices. J. Pharm. Biomed. Anal., 2005, 39(3-4), 349-363.
[32]
Zarghi, A.; Arfaei, S. Selective COX-2 inhibitors: A review of their structure-activity relationships. Iran. J. Pharm. Res. IJPR, 2011, 10(4), 655-683.
[33]
Green, G.A. Understanding NSAIDs: From aspirin to COX-2. Clin. Cornerstone, 2001, 3(5), 50-60.
[34]
Starek, M.; Krzek, J. A review of analytical techniques for determination of oxicams, nimesulide and nabumetone. Talanta, 2009, 77(3), 925-942.
[35]
Castillo, M.A.; Bruzzone, L. Indirect fluorometric determination of diclofenac sodium. Anal. Sci., 2006, 22(3), 431-433.
[36]
Small, R.E. Diclofenac sodium. Clin. Pharm., 1989, 8(8), 545-558.
[37]
Scholer, D.W.; Ku, E.C.; Boettcher, I.; Schweizer, A. Pharmacology of diclofenac sodium. Am. J. Med., 1986, 80(4), 34-38.
[38]
Maier, R.; Menassé, R.; Riesterer, L.; Pericin, C.; Ruegg, M.; Ziel, R. The pharmacology of diclofenac sodium (voltarol). Rheumatol. Rehabil., 1979(Suppl. 2), 11-21.
[39]
Suresh, E.; Sundaram, K.; Kavitha, B.; Kumar, A.N.S. Square Wave Voltammetry Sensing of Ibuprofen on Glassy Carbon Electrode. Int. J. Curr. Pharm. Res, 2016, 9, 182-188.
[40]
Bushra, R.; Aslam, N. An overview of clinical pharmacology of ibuprofen. Oman Med. J., 2010, 25(3), 155-1661.
[41]
Rainsford, K.D. Ibuprofen: Pharmacology, efficacy and safety. Inflammopharmacology, 2009, 17(6), 275-342.
[42]
Adams, S.S.; McCullough, K.F.; Nicholson, J.S. The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and antipyretic agent. Arch. Int. Pharmacodyn. Ther., 1969, 178(1), 115-129.
[43]
Evans, A.M. Comparative pharmacology of S(+)-Ibuprofen and (RS)-Ibuprofen. Clin. Rheumatol., 2001, 20(S1), 9-14.
[44]
Loudiki, A.; Hammani, H.; Boumya, W.; Lahrich, S.; Farahi, A.; Achak, M.; Bakasse, M.; El Mhammedi, M.A. Electrocatalytical effect of montmorillonite to oxidizing ibuprofen: analytical application in river water and commercial tablets. Appl. Clay Sci., 2016, 123, 99-108.
[45]
Rogers, J.; Kirby, L.C.; Hempelman, S.R.; Berry, D.L.; McGeer, P.L.; Kaszniak, A.W.; Zalinski, J.; Cofield, M.; Mansukhani, L.; Willson, P. Clinical trial of indomethacin in Alzheimer’s disease. Neurology, 1993, 43(8), 1609-1611.
[46]
Gersony, W.M.; Peckham, G.J.; Ellison, R.C.; Miettinen, O.S.; Nadas, A.S. Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study. J. Pediatr., 1983, 102(6), 895-906.
[47]
Balali-Mood, M.; Proudfoot, A.T.; Critchley, J.A.J.H.; Prescott, L.F. Mefenamic acid overdosage. Lancet, 1981, 317(8234), 1354-1356.
[48]
Kasichayanula, S.; Liu, X.; Griffen, S.C.; LaCreta, F.P.; Boulton, D.W. Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin. Diabetes Obes. Metab., 2013, 15(3), 280-283.
[49]
Winder, C.V.; Lembke, L.A.; Stephens, M.D. Comparative bioassay of drugs in adjuvant-induced arthritis in rats: Flufenamic Acid, Mefenamic Acid, and Phenylbutazone. Arthritis Rheum., 1969, 12(5), 472-482.
[50]
Ozgoli, G.; Goli, M.; Moattar, F. Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. J. Altern. Complement. Med., 2009, 15(2), 129-132.
[51]
Adhoum, N.; Monser, L.; Toumi, M.; Boujlel, K. Determination of naproxen in pharmaceuticals by differential pulse voltammetry at a platinum electrode. Anal. Chim. Acta, 2003, 495(1-2), 69-75.
[52]
Roda, R.S. Naproxen: Pharmacology and dental therapeutics. J. Can. Dent. Assoc., 1992, 58(5), 401-405.
[53]
Dorfman, R.I. Chemistry and pharmacology of naproxen. Arzneimittelforschung, 1975, 25(2A), 278-281.
[54]
Schwartz, J.I.; Vandormael, K.; Malice, M.P.; Kalyani, R.N.; Lasseter, K.C.; Holmes, G.B.; Gertz, B.J.; Gottesdiener, K.M.; Laurenzi, M.; Redfern, K-J. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet. Clin. Pharmacol. Ther., 2002, 72(1), 50-61.
[55]
Fortunato de Carvalho Rocha, W.; Luis Rosa, A.; Antônio Martins, J.; Poppi, R.J. Multivariate control charts based on net analyte signal and near infrared spectroscopy for quality monitoring of nimesulide in pharmaceutical formulations. J. Mol. Struct., 2010, 982(1-3), 73-78.
[56]
Famaey, J.P. In Vitro and in Vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: An overview. Inflamm. Res., 1997, 46(11), 437-446.
[57]
Bennett, A.; Villa, G. Nimesulide: An NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities. Expert Opin. Pharmacother., 2000, 1(2), 277-286.
[58]
Gupta, S.K.; Bansal, P.; Bhardwaj, R.K.; Velpandian, T. Comparative anti-nociceptive, anti-inflammatory and toxicity profile of nimesulide vs nimesulide and piperine combination. Pharmacol. Res., 2000, 41(6), 657-662.
[59]
Singla, A.K.; Chawla, M.; Singh, A. Review nimesulide: Some pharmaceutical and pharmacological aspects-An Update. J. Pharm. Pharmacol., 2000, 52(5), 467-486.
[60]
Ward, A.; Brogden, R.N. Nimesulide. Drugs, 1988, 36(6), 732-753.
[61]
Torriero, A.A.J.; Tonn, C.E.; Sereno, L.; Raba, J. Electrooxidation mechanism of non-steroidal anti-inflammatory drug piroxicam at glassy carbon electrode. J. Electroanal. Chem., 2006, 588(2), 218-225.
[62]
Dahl, S.L.; Ward, J.R. Pharmacology, Clinical efficacy, and adverse effects of piroxicam, A new nonsteroidal anti-inflammatory agent. Pharmacother. J. Hum. Pharmacol. Drug Ther, 1982, 2(2), 80-90.
[63]
Ishizaki, T.; Nomura, T.; Abe, T. Pharmacokinetics of Piroxicam, a New Nonsteroidal Anti-Inflammatory Agent, under Fasting and Postprandial States in Man. J. Pharmacokinet. Biopharm., 1979, 7(4), 369-381.
[64]
McEwen, J. Clinical pharmacology of piroxicam--Cyclodextrin. Clin. Drug Investig., 2000, 19(Suppl. 2), 27-31.
[65]
Brogden, R.N.; Heel, R.C.; Speight, T.M.; Avery, G.S. Piroxicam. Drugs, 1981, 22(3), 165-187.
[66]
Posac, J.R.; Vázquez, M.D.; Tascón, M.L.; Acuña, J.A.; de la Fuente, C.; Velasco, E.; Sánchez-Batanero, P. Determination of aceclofenac using adsorptive stripping voltammetric techniques on conventional and surfactant chemically modified carbon paste electrodes. Talanta, 1995, 42(2), 293-304.
[67]
Veitonmäki, T.; Tammela, T.L.J.; Auvinen, A.; Murtola, T.J. Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level. Eur. J. Cancer, 2013, 49(4), 938-945.
[68]
Calado, L.M.; Cordas, C.M.; Sousa, J.P. Acemetacin and indomethacin detection using modified carbon microelectrodes. Anal. Bioanal. Electrochem, 2013, 5(6), 665-671.
[69]
Tavares, I.A.; Bennett, A. Acemetacin and indomethacin: Differential inhibition of constitutive and inducible cyclo-oxygenases in human gastric mucosa and leucocytes. Int. J. Tissue React., 1993, 15(2), 49-53.
[70]
Sanphui, P.; Bolla, G.; Das, U.; Mukherjee, A.K.; Nangia, A. Acemetacin polymorphs: A rare case of carboxylic acid catemer and dimer synthons. CrystEngComm, 2013, 15(1), 34-38.
[71]
Dell, H.D.; Doersing, M.; Fischer, W.; Jacobi, H.; Kamp, R.; Köhler, G.; Schöllnhammer, G. Metabolism and Pharmacokinetics of Acemetacin in Man (Author’s Transl). Arzneimittelforschung, 1980, 30(8A), 1391-1398.
[72]
Kuhnert-Brandstätter, M.; Völlenklee, R. Thermoanalytische Und IR-Spektroskopische untersuchungen an polymorphen arzneisto-ffen: acemetacin, piroxicam, propranololhydrochlorid und urapidil. Fresenius’ Zeitschrift für Anal. Chemie,, 1985, 322(2), 164-169.
[73]
Notarianni, L.J.; Collins, A.J. Method for the determination of acemetacin, and non-steroidal anti-inflammatory drug, in plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl., 1987, 413, 305-308.
[74]
Beltagi, A.M. Utilization of a Montmorillonite-Ca-Modified carbon paste electrode for the stripping voltammetric determination of diflunisal in its pharmaceutical formulations and human blood. J. Appl. Electrochem., 2009, 39(12), 2375-2384.
[75]
Davies, R.O. Review of the animal and clinical pharmacology of diflunisal. Pharmacotherapy, 1983, 3(2Pt2), 9S-22S.
[76]
Steelman, S.L.; Cirillo, V.J.; Tempero, K.F. The chemistry, pharmacology and clinical pharmacology of diflunisal. Curr. Med. Res. Opin., 1978, 5(7), 506-514.
[77]
Stone, C.; Arman, C.; Lotti, V.; Minsker, D.; Risley, E.; Bagdon, W.; Bokelman, D.; Jensen, R.; Mendlowski, B.; Tate, C. Pharmacology and toxicology of diflunisal. Br. J. Clin. Pharmacol., 1977, 4(S1), 19S-29S.
[78]
Brogden, R.N.; Heel, R.C.; Pakes, G.E.; Speight, T.M.; Avery, G.S. Diflunisal. Drugs, 1980, 19(2), 84-106.
[79]
Sturm, J.C.; Canelo, H.; Nuñez-Vergara, L.J.; Squella, J.A. Voltammetric study of ketorolac and its differential pulse polarographic determination in pharmaceuticals. Talanta, 1997, 44(5), 931-937.
[80]
Mishra, A.; Veerasamy, R.; Jain, P.K.; Dixit, V.K.; Agrawal, R.K. Synthesis, characterization and pharmacological evaluation of amide prodrugs of ketorolac. Eur. J. Med. Chem., 2008, 43(11), 2464-2472.
[81]
Buckley, M.M-T.; Brogden, R.N. Ketorolac. Drugs, 1990, 39(1), 86-109.
[82]
Handley, D.A.; Cervoni, P.; McCray, J.E.; McCullough, J.R. Preclinical enantioselective pharmacology of (R)- and (S)- ketorolac. J. Clin. Pharmacol., 1998, 38(2S), 25S-35S.
[83]
Litvak, K.M.; McEvoy, G.K. Ketorolac, an injectable nonnarcotic analgesic. Clin. Pharm., 1990, 9(12), 921-935.
[84]
Rooks, W.H. The pharmacologic activity of ketorolac tromethamine. Pharmacother. J. Hum. Pharmacol. Drug Ther., 1990, 10(6P2), 1-10.
[85]
Beltagi, A.; El-Attar, M.; Ghoneim, E. Adsorptive stripping voltammetric determination of the anti-inflammatory drug tolmetin in bulk form, pharmaceutical formulation and human serum. Open Chem., 2007, 5(3), 835-845.
[86]
Selley, M.L.; Glass, J.; Triggs, E.J.; Thomas, J. Pharmacokinetic studies of tolmetin in man. Clin. Pharmacol. Ther., 1975, 17(5), 599-605.
[87]
Brogden, R.N.; Heel, R.C.; Speight, T.M.; Avery, G.S. Tolmetin. Drugs, 1978, 15(6), 429-450.
[88]
Caruso, A.; Cutuli, V.M.; De Bernardis, E.; Attaguile, G.; Amico-Roxas, M. Pharmacological properties and toxicology of MED-15, a prodrug of tolmetin. Drugs Exp. Clin. Res., 1992, 18(11-12), 481-485.
[89]
Beirne, J.A.; Bianchine, J.R.; Johnson, P.C.; Wortham, G.F. Gastrointestinal blood loss caused by tolmetin, aspirin, and indomethacin. Clin. Pharmacol. Ther., 1974, 16(5part1), 821-825.
[90]
Selley, M.L.; Madsen, B.W.; Thomas, J. Protein binding of tolmetin. Clin. Pharmacol. Ther., 1978, 24(6), 694-705.
[91]
Flores-Murrieta, F.J.; Ko, H.C.; Flores-Acevedo, D.M.; López-Muñoz, F.J.; Jusko, W.J.; Sale, M.E.; Castañeda-Hernández, G. Pharmacokinetic-Pharmacodynamic modeling of tolmetin antinociceptive effect in the rat using an indirect response model: a population approach. J. Pharmacokinet. Pharmacodyn., 1998, 26(5), 547-557.
[92]
Sumner, D.D.; Dayton, P.G.; Cucinell, S.A.; Plostnieks, J. Metabolism of tolmetin in rat, monkey, and man. Drug Metab. Dispos., 1975, 3(4), 283-286.
[93]
Gopu, G.; Muralidharan, B.; Vedhi, C.; Manisankar, P. Determination of three analgesics in pharmaceutical and urine sample on nano poly (3, 4-Ethylenedioxythiophene) modified electrode. Ionics (Kiel), 2012, 18(1-2), 231-239.
[94]
Pierre, S.C.; Schmidt, R.; Brenneis, C.; Michaelis, M.; Geisslinger, G.; Scholich, K. Inhibition of Cyclooxygenases by Dipyrone. Br. J. Pharmacol., 2009, 151(4), 494-503.
[95]
Huguley, C.M. Agranulocytosis induced by dipyrone, a hazardous antipyretic and analgesic. JAMA, 1964, 189(12), 938-941.
[96]
Hinz, B.; Cheremina, O.; Bachmakov, J.; Renner, B.; Zolk, O.; Fromm, M.F.; Brune, K. Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: New insights into the pharmacology of an old analgesic. FASEB J., 2007, 21(10), 2343-2351.
[97]
Abd El-Hady, D.; Youssef, A.K. Hyphenation of Ionic Liquid Albumin Glassy Carbon Biosensor or Protein Label-Free Sensor with Differential Pulse Stripping Voltammetry for Interaction Studies of Human Serum Albumin with Fenoprofen Enantiomers. Anal. Chim. Acta, 2013, 772, 68-74.
[98]
Rubin, A.; Knadler, M.P.; Ho, P.P.K.; Bechtol, L.D.; Wolen, R.L. Stereoselective inversion of (R)-Fenoprofen to (S)-Fenoprofen in humans. J. Pharm. Sci., 1985, 74(1), 82-84.
[99]
Gruber, C.M. Clinical pharmacology of fenoprofen: A review. J. Rheumatol., 1976, 2, 8-17.
[100]
Volland, C.; Sun, H.; Dammeyer, J.; Benet, L.Z. Stereoselective degradation of the fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. Drug Metab. Dispos., 1991, 19(6), 1080-1086.
[101]
Brogden, R.N.; Pinder, R.M.; Speight, T.M.; Avery, G.S. Fenoprofen. Drugs, 1977, 13(4), 241-265.
[102]
Bozal, B.; Uslu, B. Applications of carbon based electrodes for voltammetric determination of lornoxicam in pharmaceutical dosage form and human serum. Comb. Chem. High Throughput Screen., 2010, 13(7), 598-609.
[103]
Prakash, A.; Patyar, S.; Byrav, P.; Medhi, B.; Prakash, A.; Patyar, S.; Wadhwa, S. Lornoxicam: A newer NSAID. IJPMR, 2009, 20(271), 27-31.
[104]
Skjodt, N.M.; Davies, N.M. Clinical pharmacokinetics of lornoxicam. Clin. Pharmacokinet., 1998, 34(6), 421-428.
[105]
Bianchi, M.; Panerai, A.E. Effects of lornoxicam, piroxicam, and meloxicam in a model of thermal hindpaw hyperalgesia induced by formalin injection in rat tail. Pharmacol. Res., 2002, 45(2), 101-105.
[106]
Balfour, J.A.; Fitton, A.; Barradell, L.B. Lornoxicam. Drugs, 1996, 51(4), 639-657.
[107]
Pruss, T.P.; Stroissnig, H.; Radhofer-Welte, S.; Wendtlandt, W.; Mehdi, N.; Takacs, F.; Fellier, H. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad. Med. J., 1990, 66(Suppl. 4), S18-S21.
[108]
Hillstrom, C.; Jakobsson, J.G. Lornoxicam: Pharmacology and usefulness to treat acute postoperative and musculoskeletal pain a narrative review. Expert Opin. Pharmacother., 2013, 14(12), 1679-1694.
[109]
Reguera, C.; Ortiz, M.C.C.; Arcos, M.J.J. Differential pulse voltammetric simultaneous determination of four anti-inflammatory drugs by using soft modelling. Electroanalysis, 2002, 14(24), 1699-1706.
[110]
Bradshaw, D.; Cashin, C.H.; Kennedy, A.J.; Roberts, N.A. Pharmacological and biochemical activities of tenoxicam (Ro 12-0068), a new non-steroidal anti-inflammatory drug. Agents Actions, 1984, 15(5-6), 569-577.
[111]
Todd, P.A.; Clissold, S.P. Tenoxicam. Drugs, 1991, 41(4), 625-646.
[112]
Nilsen, O.G. Clinical pharmacokinetics of tenoxicam. Clin. Pharmacokinet., 1994, 26(1), 16-43.
[113]
Altinoz, S.; Nemutlu, E.; Kr, S. Polarographic behaviour of meloxicam and its determination in tablet preparations and spiked plasma. Farmaco, 2002, 57(6), 463-468.
[114]
Engelhardt, G. Pharmacology of meloxicam, a new non-steroidal anti-inflammatory drug with an improved safety profile through preferential inhibition of COX-2. Rheumatology, 1996, 35(Suppl. 1), 4-12.
[115]
Ogino, K.; Hatanaka, K.; Kawamura, M.; Katori, M.; Harada, Y. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for Cyclooxygenase-2 over Cyclooxygenase-1. Pharmacology, 1997, 55(1), 44-53.
[116]
Ortiz, M.I.; Castañeda-Hernández, G.; Granados-Soto, V. Pharmacological evidence for the activation of Ca2+-Activated K+ channels by meloxicam in the formalin test. Pharmacol. Biochem. Behav., 2005, 81(4), 725-731.
[117]
Engelhardt, G.; Homma, D.; Schlegel, K.; Utzmann, R.; Schnitzler, C. Anti-Inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance. Inflamm. Res., 1995, 44(10), 423-433.
[118]
Ogino, K.; Saito, K.; Osugi, T.; Satoh, H. Meloxicam (Mobic): A review of its pharmacological and clinical profile. Nippon Yakurigaku Zasshi, 2002, 120(6), 391-397.
[119]
Ghoneim, M.; Beltagi, A. Adsorptive stripping voltammetric determination of the anti-inflammatory drug celecoxib in pharmaceutical formulation and human serum. Talanta, 2003, 60(5), 911-921.
[120]
Nezhadali, A.; Sadeghzadeh, S. Experimental design-artificial neural network-genetic algorithm optimization and computer-assisted design of celecoxib molecularly imprinted polymer/carbon nanotube sensor. J. Electroanal. Chem., 2017, 795, 32-40.
[121]
Yilmaz, S.; Uslu, B.; Özkan, S.A. Anodic oxidation of etodolac and its square wave and differential pulse voltammetric determination in pharmaceuticals and human serum. Talanta, 2001, 54(2), 351-360.
[122]
Humber, L.G. Etodolac: The chemistry, pharmacology, metabolic disposition, and clinical profile of a novel anti-inflammatory pyranocarboxylic acid. Med. Res. Rev., 1987, 7(1), 1-28.
[123]
Glaser, K.; Sung, M-L.; O’Neill, K.; Belfast, M.; Hartman, D.; Carlson, R.; Kreft, A.; Kubrak, D.; Hsiao, C-L.; Weichman, B. Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1. Eur. J. Pharmacol., 1995, 281(1), 107-111.
[124]
Inoue, K.; Fujisawa, H.; Sasaki, Y.; Nishimura, T.; Nishimura, I.; Inoue, Y.; Yokota, M.; Masuda, T.; Ueda, F.; Shibata, Y. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac. Arzneimittelforschung, 1991, 41(3), 228-235.
[125]
Balfour, J.A.; Buckley, M.M-T. Etodolac. Drugs, 1991, 42(2), 274-299.
[126]
Cappello, B.; di Maio, C.; Iervolino, M.; Miro, A.; Calignano, A. Etodolac/cyclodextrin formulations: Physicochemical characteriza-tion and in Vivo pharmacological studies. Drug Dev. Ind. Pharm., 2009, 35(7), 877-886.
[127]
Boni, J.; Korth-Bradley, J.; McGoldrick, K.; Appel, A.; Cooper, S. Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. J. Clin. Pharmacol., 1999, 39(7), 729-737.
[128]
Ghoneim, M.M.; Beltagi, A.M. Adsorptive stripping voltammetric determination of the anti-inflammatory drug celecoxib in pharmaceutical formulation and human serum. Talanta, 2003, 60(5), 911-921.
[129]
Santhosh, P.; Senthil Kumar, N.; Renukadevi, M.; Gopalan, A.I.; Vasudevan, T.; Lee, K-P. Enhanced electrochemical detection of ketorolac tromethamine at polypyrrole modified glassy carbon electrode. Anal. Sci., 2007, 23(4), 475-478.
[130]
Goyal, R.N.; Chatterjee, S.; Agrawal, B. Electrochemical investigations of diclofenac at edge plane pyrolytic graphite electrode and its determination in human urine. Sens. Actuators B Chem., 2010, 145(2), 743-748.
[131]
Muralidharan, B.; Gopu, G.; Vedhi, C.; Manisankar, P. Voltammetric determination of analgesics using a montmorillonite modified electrode. Appl. Clay Sci., 2008, 42(1-2), 206-213.
[132]
Wang, C.Y.; Wang, Z.X.; Guan, J.; Hu, X.Y. Voltammetric determination of meloxicam in pharmaceutical formulation and human serum at glassy carbon electrode modified by cysteic acid formed by electrochemical oxidation of L-Cysteine. Sensors, 2005, 6(9), 1139-1152.
[133]
Norouzi, P.; Dousty, F.; Ganjali, M.R.; Daneshgar, P. Dysprosium nanowire modified carbon paste electrode for the simultaneous determination of naproxen and paracetamol: Application in pharmaceutical formulation and biological fluid. Int. J. Electrochem. Sci., 2009, 4, 1373-1386.
[134]
Bukkitgar, S.D.; Shetti, N.P.; Kulkarni, R.M.; Doddamani, M.R. Electro-Oxidation of nimesulide at 5% barium-doped zinc oxide nanoparticle modified glassy carbon electrode. J. Electroanal. Chem., 2016, 762, 37-42.
[135]
Gholivand, M.B.; Malekzadeh, G.; Derakhshan, A.A. Boehmite nanoparticle modified carbon paste electrode for determination of piroxicam. Sens. Actuators B Chem., 2014, 201, 378-386.
[136]
Meng, X.; Xu, Z.; Wang, M.; Yin, H.; Ai, S. Electrochemical behavior of antipyrine at a Bi 2 S 3 modified glassy carbon electrode and its determination in pharmaceutical formulations. Anal. Methods, 2012, 4(6), 1736-1741.
[137]
Bashkatova, N.V.; Korotkova, E.I.; Karbainov, Y.A.; Yagovkin, A.Y.; Bakibaev, A.A. Electrochemical, quantum-chemical and antioxidant properties of antipyrine and its derivatives. J. Pharm. Biomed. Anal., 2005, 37(5), 1143-1147.
[138]
Arkan, E.; Karimi, Z.; Shamsipur, M.; Saber, R. Electrochemical determination of celecoxib on a graphene based carbon ionic liquid electrode modified with gold nanoparticles and its application to pharmaceutical analysis. Anal. Sci., 2013, 29(8), 855-860.
[139]
Blanco‐López, M.C.; Fernández‐Llano, L.; Lobo‐Castañón, M.J.; Miranda‐Ordieres, A.J.; Tuñón‐Blanco, P. Voltammetry of diclofenac at graphite, carbon composites, and molecularly imprinted polymer‐composite electrodes. Anal. Lett., 2004, 37(5), 915-927.
[140]
Daneshgar, P.; Norouzi, P.; Ganjali, M.R.; Dinarvand, R.; Moosavi-Movahedi, A.A. Determination of diclofenac on a dysprosium nanowire-modified carbon paste electrode accomplished in a flow injection system by advanced filtering. Sensors, 2009, 9(10), 7903-7918.
[141]
Manea, F.; Ihos, M.; Remes, A.; Burtica, G.; Schoonman, J. Electrochemical determination of diclofenac sodium in aqueous solution on Cu-Doped Zeolite-Expanded Graphite-Epoxy electrode. Electroanalysis, 2010, 22(17-18), 2058-2063.
[142]
Ciltas, U.; Yilmaz, B.; Kaban, S.; Akcay, B.K.; Nazik, G. Square wave voltammetric determination of diclofenac in pharmaceutical preparations and human serum. Iran. J. Pharm. Res. IJPR, 2015, 14(3), 715-722.
[143]
Chethana, B.K.; Basavanna, S.; Naik, Y.A. Voltammetric Determination of Diclofenac Sodium Using Tyrosine- Modi Fi Ed Carbon Paste Electrode. Ind. Eng. Chem. Res., 2012, 51(31), 10287-10295.
[144]
Fernández-Llano, L.; Blanco-López, M.C.; Lobo-Castañón, M.J.; Miranda-Ordieres, A.J.; Tuñón-Blanco, P. Determination of diclofenac in urine samples by molecularly-imprinted solid-phase extraction and adsorptive differential pulse voltammetry. Electroanalysis, 2007, 19(15), 1555-1561.
[145]
Arvand, M.; Hassannezhad, M. Square wave voltammetric determination of uric acid and diclofenac on multi-walled carbon nanotubes decorated with magnetic core-shell Fe3O4@SiO2 nanoparticles as an enhanced sensing interface. Ionics (Kiel), 2015, 21(12), 3245-3256.
[146]
Karuppiah, C.; Cheemalapati, S.; Chen, S.M.; Palanisamy, S. Carboxyl-Functionalized graphene oxide-modified electrode for the electrochemical determination of nonsteroidal anti-inflammatory drug diclofenac. Ionics (Kiel), 2014, 21(1), 231-238.
[147]
Sarhangzadeh, K.; Khatami, A.A.; Jabbari, M.; Bahari, S. Simultaneous determination of diclofenac and indomethacin using a sensitive electrochemical sensor based on multiwalled carbon nanotube and ionic liquid nanocomposite. J. Appl. Electrochem., 2013, 43(12), 1217-1224.
[148]
Thiagarajan, S.; Rajkumar, M.; Chen, S. Nano TiO 2 -PEDOT film for the simultaneous detection of ascorbic acid and diclofenac. Int. J. Electrochem. Sci., 2012, 7, 2109-2122.
[149]
Yilmaz, B.; Kaban, S.; Akcay, B.K.; Ciltas, U. Differential pulse voltammetric determination of diclofenac in pharmaceutical preparations and human serum. Braz. J. Pharm. Sci., 2015, 51(2), 285-294.
[150]
Oliveira, T.M.B.F.; Pessoa, G. de P.; dos Santos, A.B.; de Lima-Neto, P.; Correia, A.N. Simultaneous electrochemical sensing of emerging organic contaminants in full-scale sewage treatment plants. Chem. Eng. J., 2015, 267, 347-354.
[151]
Afkhami, A.; Bahiraei, A.; Madrakian, T. Gold Nanoparticle/multi-Walled carbon nanotube modified glassy carbon electrode as a sensitive voltammetric sensor for the determination of diclofenac sodium. Mater. Sci. Eng. C, 2016, 59, 168-176.
[152]
Arvand, M.; Gholizadeh, T.M.; Zanjanchi, M.A. MWCNTs/ Cu(OH) 2 nanoparticles/IL nanocomposite modified glassy carbon electrode as a voltammetric sensor for determination of the non-steroidal anti-inflammatory drug diclofenac. Mater. Sci. Eng. C, 2012, 32(6), 1682-1689.
[153]
Goodarzian, M.; Khalilzade, M.A.; Karimi, F.; Kumar Gupta, V.; Keyvanfard, M.; Bagheri, H.; Fouladgar, M. Square wave voltammetric determination of diclofenac in liquid phase using a novel ionic liquid multiwall carbon nanotubes paste electrode. J. Mol. Liq., 2014, 197, 114-119.
[154]
Mokhtari, A.; Karimi-Maleh, H.; Ensafi, A.A.; Beitollahi, H. Application of modified multiwall carbon nanotubes paste electrode for simultaneous voltammetric determination of morphine and diclofenac in biological and pharmaceutical samples. Sens. Actuators B Chem., 2012, 169, 96-105.
[155]
Sayn, F.; Kr, S. Analysis of diflunisal by electrochemical methods. J. Pharm. Biomed. Anal., 2001, 25(1), 153-163.
[156]
Ramadan, A.A.; Mandil, H.; Hafez, B. Determination of dipyrone in pure form and pharmaceutical formulations by differential pulse polarographic analysis. Asian J. Chem., 2011, 23, 403.
[157]
Teixeira, M.; Marcolino-Junior, L.; Fatibello-Filho, O.; Moraes, F.; Nunes, R. Determination of Analgesics (Dipyrone and Acetaminophen) in pharmaceutical preparations by cyclic voltammetry at a copper(ii) hexacyanoferrate(iii) modified carbon paste electrode. Curr. Anal. Chem., 2009, 5(4), 303-310.
[158]
Teixeira, M.F.S.; Marcolino-júnior, L.H.; Fatibello-filho, O.; Dockal, E.R. Voltammetric determination of dipyrone using a modified carbon-paste electrode., 2004, 15(6), 803-808.
[159]
Martin, C.S.; Teixeira, M.F.S. Electrocatalytic Study of an electrode modified with reactive blue 4 dye covalently immobilized on amine-functionalized silica. J. Solid State Electrochem., 2012, 16(12), 3877-3886.
[160]
Baranowska, I.; Markowski, P.; Gerle, A.; Baranowski, J. Deter-mination of selected drugs in human urine by differential pulse voltammetry technique. Bioelectrochemistry, 2008, 73(1), 5-10.
[161]
Ghica, M.E.; Ferreira, G.M.; Brett, C.M.A. Poly(thionine)-Carbon nanotube modified carbon film electrodes and application to the simultaneous determination of acetaminophen and dipyrone. J. Solid State Electrochem., 2015, 19(9), 2869-2881.
[162]
Muralidharan, B.; Gopu, G.; Vedhi, C.; Manisankar, P. Determination of analgesics in pharmaceutical formulations and urine samples using nano polypyrrole modified glassy carbon electrode. J. Appl. Electrochem., 2009, 39(8), 1177-1184.
[163]
Jain, R.; Shrivastava, S.A. Graphene-Polyaniline-Bi2O3 hybrid film sensor for voltammetric quantification of anti-inflammatory drug etodolac. J. Electrochem. Soc., 2014, 161(4), H189-H194.
[164]
Sabry, S.M.; Mahgoub, H. Voltammetric, spectrofluorimetric and spectrophotometric methods to determine flufenamic acid. J. Pharm. Biomed. Anal., 1999, 21(5), 993-1001.
[165]
Amor-García, I.; Blanco-López, M.C.; Lobo-Castañón, M.J.; Miranda-Ordieres, A.J.; Tuñón-Blanco, P. Flufenamic acid determination in human serum by adsorptive voltammetry with in situ surfactant modified carbon paste electrodes. Electroanalysis, 2005, 17(17), 1555-1562.
[166]
Santini, A.O.; de Oliveira, J.E.; Pezza, H.R.; Pezza, L. A new potentiometric ibuprofenate ion sensor immobilized in a graphite matrix for determination of ibuprofen in tablets. Microchem. J., 2006, 84(1-2), 44-49.
[167]
Lima, A.B.; Faria, E.O.; Montes, R.H.O.; Cunha, R.R.; Richter, E.M.; Munoz, R.A.A.; dos Santos, W.T.P. Electrochemical oxidation of ibuprofen and its voltammetric determination at a boron-doped diamond electrode. Electroanalysis, 2013, 25(7), 1585-1588.
[168]
Manea, F.; Motoc, S.; Pop, A.; Remes, A.; Schoonman, J. Silver-Functionalized carbon nanofiber composite electrodes for ibuprofen detection. Nanoscale Res. Lett., 2012, 7(1), 331.
[169]
Lima, A.B.; Torres, L.M.F.C.; Guimarães, C.F.R.C.; Verly, R.M.; L.M., da Silva; Carvalho Júnior, Á.D.; W.T.P., dos Santos Simultaneous determination of paracetamol and ibuprofen in pharmaceutical samples by differential pulse voltammetry using a boron-doped diamond electrode. J. Braz. Chem. Soc., 2014, 25(3), 478-483.
[170]
Roushani, M.; Shahdost-Fard, F. Fabrication of an ultrasensitive ibuprofen nanoaptasensor based on covalent attachment of aptamer to electrochemically deposited gold-nanoparticles on glassy carbon electrode. Talanta, 2015, 144, 510-516.
[171]
Amin, S.; Soomro, M.T.; Memon, N.; Solangi, A.R. Sirajuddin; Qureshi, T.; Behzad, A.R. Disposable screen printed graphite electrode for the direct electrochemical determination of ibuprofen in surface water. Environ. Nanotechnol. Monit. Manag., 2014, 1-2, 8-13.
[172]
Radi, A.; Beltagi, A.; Ghoneim, M. Determination of ketorolac in human serum by square wave adsorptive stripping voltammetry. Talanta, 2001, 54(2), 283-289.
[173]
Babaei, A.; Afrasiabi, M.; Babazadeh, M. A glassy carbon electrode modified with multiwalled carbon nanotube/chitosan composite as a new sensor for simultaneous determination of acetaminophen and mefenamic acid in pharmaceutical preparations and biological samples. Electroanalysis, 2010, 22(15), 1743-1749.
[174]
Radi, A-E.; Ghoneim, M.; Beltagi, A. Cathodic adsorptive stripping square-wave voltammetry of the anti-inflammatory drug meloxicam. Chem. Pharm. Bull. (Tokyo), 2001, 49(10), 1257-1260.
[175]
Huang, H.; Gao, H.Y.; Zeng, Y.H. Adsorptive voltammetric behavior of meloxicam. Acta Pharm. Sin. B, 2000, 35, 699-704.
[176]
Beltagi, A.M.; Ghoneim, M.M.; Radi, A. Electrochemical reduction of meloxicam at mercury electrode and its determination in tablets. J. Pharm. Biomed. Anal., 2002, 27(5), 795-801.
[177]
Cheemalapati, S.; Devadas, B.; Chen, S-M. Novel Poly-L-Lysine/carboxyl-Group enriched graphene oxide/modified electrode preparation, characterization and applications for the electrochemical determination of meloxicam in pharmaceutical tablets and blood serum. Anal. Methods, 2014, 6(20), 8426-8434.
[178]
Azodi-Deilami, S.; Asadi, E.; Abdouss, M.; Ahmadi, F.; Najafabadi, A.H.; Farzaneh, S. Determination of meloxicam in plasma samples using a highly selective and sensitive voltammetric sensor based on carbon paste electrodes modified by molecularly imprinted polymer nanoparticle-multiwall carbon nanotubes. Anal. Methods, 2015, 7(4), 1280-1292.
[179]
Radi, A.; El Ries, M.A.; El-Anwar, F.; El-Sherif, Z. Electrochemical oxidation of meloxicam and its determination in tablet dosage form. Anal. Lett., 2001, 34(5), 739-748.
[180]
Wang, C.; Shao, X.; Liu, Q.; Qu, Q.; Yang, G.; Hu, X. Differential pulse voltammetric determination of nimesulide in pharmaceutical formulation and human serum at glassy carbon electrode modified by cysteic acid/CNTs based on electrochemical oxidation of l-cysteine. J. Pharm. Biomed. Anal., 2006, 42(2), 237-244.
[181]
Aguilar-Lira, G.Y.; Romero, G.A.Á.; Rojas-Hernández, A.; Páez-Hernández, M.E.; Rodríguez-Ávila, J.A.; Romero-Romo, M.A. voltammetric analysis of naproxen in graphite electrodes and its determination in pharmaceutical samples. Electroanalysis, 2014, 26(7), 1573-1581.
[182]
Afzali, F.; Rounaghi, G.; Zavar, M.H.A.; Ashraf, N. Supramolecular β-Cyclodextrin/Multi-Walled carbon nanotube paste electrode for amperometric detection of naproxen. J. Electrochem. Soc., 2016, 163(3), B56-B61.
[183]
Tashkhourian, J.; Hemmateenejad, B.; Beigizadeh, H.; Hosseini-Sarvari, M.; Razmi, Z. ZnO nanoparticles and multiwalled carbon nanotubes modified carbon paste electrode for determination of naproxen using electrochemical techniques. J. Electroanal. Chem., 2014, 714-715, 103-108.
[184]
Suryanarayanan, V.; Zhang, Y.; Yoshihara, S.; Shirakashi, T. Voltammetric assay of naproxen in pharmaceutical formulations using boron-doped diamond electrode. Electroanalysis, 2005, 17(11), 925-932.
[185]
Ghavami, R.; Navaee, A. Determination of nimesulide in human serum using a glassy carbon electrode modified with sic nanoparticles. Mikrochim. Acta, 2012, 176(3-4), 493-499.
[186]
Furlanetto, S.; Orlandini, S.; Aldini, G.; Gotti, R.; Dreassi, E.; Pinzauti, S. Designing experiments to optimise and validate the adsorptive stripping voltammetric determination of nimesulide. Anal. Chim. Acta, 2000, 413(1-2), 229-239.
[187]
Álvarez-Lueje, A.; Vásquez, P.; Núñez-Vergara, L.J.; Squella, J.A. Voltammetric study of nimesulide and its differential pulse polarographic determination in pharmaceuticals. Electroanalysis, 1997, 9(15), 1209-1213.
[188]
Zhang, J.; Tan, X.; Zhao, D.; Tan, S.; Huang, Z.; Mi, Y.; Huang, Z. Study of nimesulide and its determination using multiwalled carbon nanotubes modified glassy carbon electrodes. Electrochim. Acta, 2010, 55(7), 2522-2526.
[189]
El-Sayed, G.O.; Yasin, S.A.; Ries, M.A. El; El-Badawy, A.A. Adsorptive voltammetric determination of nimesulide at glassy carbon electrode. Lat. Am. J. Pharm. Am. J. Pharm, 2009, 28(5), 741-746.
[190]
Asadpour-zeynali, K.; Majidi, M.R.; Zarifi, M. Carbon ceramic electrode incorporated with zeolite zsm-5 for determination of piroxicam. Inst. Pet, 2010, 8(1), 155-162.
[191]
Karimi-Maleh, H.; Tahernejad-Javazmi, F.; Ensafi, A.A.; Moradi, R.; Mallakpour, S.; Beitollahi, H. A high sensitive biosensor based on FePt/CNTs nanocomposite/N-(4-Hydroxyphenyl)-3,5-dinitro-benzamide modified carbon paste electrode for simultaneous determination of glutathione and piroxicam. Biosens. Bioelectron., 2014, 60, 1-7.
[192]
Abbaspour, A.; Mirzajani, R. Electrochemical monitoring of piroxicam in different pharmaceutical forms with multi-walled carbon nanotubes paste electrode. J. Pharm. Biomed. Anal., 2007, 44(1), 41-48.
[193]
Gholivand, M.B.; Karimian, N. Development of piroxicam sensor based on molecular imprinted polymer-modified carbon paste electrode. Mater. Sci. Eng. C, 2011, 31(8), 1844-1851.
[194]
Wong, A.; Santos, A.M.; Fatibello-Filho, O. Determination of piroxicam and nimesulide using an electrochemical sensor based on reduced graphene oxide and PEDOT:PSS. J. Electroanal. Chem., 2017, 799, 547-555.
[195]
Shahrokhian, S.; Jokar, E.; Ghalkhani, M. Electrochemical determination of piroxicam on the surface of pyrolytic graphite electrode modified with a film of carbon nanoparticle-chitosan. Mikrochim. Acta, 2010, 170(1), 141-146.
[196]
Shaikh, T. uddin, S.J.; Talpur, F.N.; Khaskeli, A.R.; Agheem, M. H.; Shah, M.R.; Sherazi, T.H.; Siddiqui, S. Ultrasensitive determination of piroxicam at diflunisal-derived gold nanoparticle-modified glassy carbon electrode. J. Electron. Mater., 2017, 46(10), 5957-5966.
[197]
Babaei, A.; Sohrabi, M.; Afrasiabi, M. A sensitive simultaneous determination of epinephrine and piroxicam using a glassy carbon electrode modified with a nickel hydroxide nanoparticles/multi-walled carbon nanotubes composite. Electroanalysis, 2012, 24(12), 2387-2394.
[198]
Babaei, A.; Afrasiabi, M. A glassy carbon electrode modified with MCM-41/nickel hydroxide nanoparticle/multiwalled carbon nanotube composite as a sensor for the simultaneous determination of dopamine, piroxicam, and cefixime. Ionics (Kiel), 2015, 21(6), 1731-1740.
[199]
Norouzi, P.; Ganjali, M.R.; Labbafi, S.; Mohammadi, A. Subsecond FFT-Adsorptive voltammetric technique as a novel method for subnano level monitoring of piroxicam in its tablets and bulk form at au microelectrode in flowing solutions. Anal. Lett., 2007, 40(4), 747-762.
[200]
Norouzi, P.; Ghaheri, N. β-Cyclodextrine modified carbon paste electrode as a selective sensor for determination of piroxicam using flow injection cyclic voltammerty analytical & bioanalytical electrochemistry. Anal. Bioanal. Electrochem. Anal. Bioanal. Electrochem, 2011, 3(1), 87-101.
[201]
Karim-Nezhad, G.; Khorablou, Z.; Dorraji, P. Applications of polymer and nanoscale carbon-based materials in piroxicam sensing and detection. Sens. Lett., 2017, 15(3), 282-288.
[202]
Attia, A.K.; Rashed, N.S.; Fouad, M.M.; Wasfy, R.A. Electrochemical determination of tolfenamic acid in bulk, tablets and urine. Anal. Bioanal. Electrochem, 2017, 9(4), 453-468.
[203]
Xuecai, T.; Yaohua, L.; Shaowei, W. Adsorptive stripping voltammetry of tolmetin. Chin. J. Anal. Chem., 1998, 4, 1-17.
Download PDF Flyer